Atlas Trials

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

Clinical trial NCT02161718 · COMPLETED

Trial details

NCT number
NCT02161718
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SchizophreniaAlcohol Use Disorder
Start date
2014-05-01
Primary completion
2017-01-11
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.